NBC4

National Bioproducts Corporation (NBC) is a leading South African biotechnology company specializing in the manufacture of plasma-derived medicinal products. The company processes human plasma to produce a wide range of essential therapies, including albumin, intravenous immunoglobulins, and coagulation factors for the treatment of hemophilia. NBC plays a critical role in the healthcare infrastructure of Southern Africa by ensuring a stable and safe supply of life-saving blood products. Its manufacturing facilities adhere to international quality standards, providing critical treatments for immune disorders, emergency medicine, and chronic genetic conditions.